Cutaneous angiosarcoma of the scalp
dc.contributor.author | Pawlik, Timothy M. | en_US |
dc.contributor.author | Paulino, Augusto F. G. | en_US |
dc.contributor.author | Mcginn, Cornelius J. | en_US |
dc.contributor.author | Baker, Laurence H. | en_US |
dc.contributor.author | Cohen, Deborah S. | en_US |
dc.contributor.author | Morris, Jeffery S. | en_US |
dc.contributor.author | Rees, Riley S. | en_US |
dc.contributor.author | Sondak, Vernon K. | en_US |
dc.date.accessioned | 2006-04-19T13:31:40Z | |
dc.date.available | 2006-04-19T13:31:40Z | |
dc.date.issued | 2003-10-15 | en_US |
dc.identifier.citation | Pawlik, Timothy M.; Paulino, Augusto F.; Mcginn, Cornelius J.; Baker, Laurence H.; Cohen, Deborah S.; Morris, Jeffery S.; Rees, Riley; Sondak, Vernon K. (2003)."Cutaneous angiosarcoma of the scalp." Cancer 98(8): 1716-1726. <http://hdl.handle.net/2027.42/34380> | en_US |
dc.identifier.issn | 0008-543X | en_US |
dc.identifier.issn | 1097-0142 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/34380 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=14534889&dopt=citation | en_US |
dc.description.abstract | BACKGROUND Angiosarcoma is a malignant tumor of vascular endothelial cells that arises in the head and neck. It is a rare, difficult to treat, and lethal tumor. METHODS Clinical data from patients who were diagnosed with angiosarcoma of the scalp between 1975 and 2002 at the University of Michigan were reviewed. Analysis was performed to assess for factors impacting time to recurrence and survival. RESULTS The study was comprised of 29 patients with a median age of 71.0 years. Most patients presented after a delay in diagnosis with either a bruise-like macule (48.3%) or a nonbruise-like nodule (51.7%). Seventy-five percent of patients had pathologic Stage T2 disease, and 76% of patients had high-grade tumors. Virtually all patients underwent surgical excision (96.6%); however, negative surgical margins were achieved in only 21.4% of patients. Multiple lesions on presentation were associated with a shorter time to recurrence ( P = 0.02). The median actuarial survival was 28.4 months. Younger patients and patients with Stage T1 disease had improved survival ( P = 0.024 and P = 0.013, respectively). Radiation therapy was associated significantly with a decreased chance of death (hazard ratio, 0.16; P = 0.006). CONCLUSIONS Although surgery remains the first option for the treatment of patients with angiosarcoma of the scalp, achieving negative margins often is impossible. Patients who are younger and who have less extensive disease fare better. Postoperative radiation therapy should be employed routinely, as it may lead to improved survival. Cancer 2003. © 2003 American Cancer Society. DOI 10.1002/cncr.11667 | en_US |
dc.format.extent | 198918 bytes | |
dc.format.extent | 3118 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.language.iso | en_US | |
dc.publisher | Wiley Subscription Services, Inc., A Wiley Company | en_US |
dc.subject.other | Life and Medical Sciences | en_US |
dc.subject.other | Cancer Research, Oncology and Pathology | en_US |
dc.title | Cutaneous angiosarcoma of the scalp | en_US |
dc.type | Article | en_US |
dc.rights.robots | IndexNoFollow | en_US |
dc.subject.hlbsecondlevel | Oncology and Hematology | en_US |
dc.subject.hlbsecondlevel | Public Health | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | Department of Surgery, University of Michigan Medical School, Ann Arbor, Michigan | en_US |
dc.contributor.affiliationum | Department of Pathology, University of Michigan Medical School, Ann Arbor, Michigan | en_US |
dc.contributor.affiliationum | Department of Radiation Oncology, University of Michigan Medical School, Ann Arbor, Michigan | en_US |
dc.contributor.affiliationum | Department of Medical Oncology, University of Michigan Medical School, Ann Arbor, Michigan | en_US |
dc.contributor.affiliationum | Department of Surgery, University of Michigan Medical School, Ann Arbor, Michigan | en_US |
dc.contributor.affiliationum | Department of Surgery, University of Michigan Medical School, Ann Arbor, Michigan ; Fax: (734) 647-9647 ; The University of Michigan Hospitals, 3306 Cancer Center, 1500 East Medical Center Drive, Ann Arbor, MI 48109-0932 | en_US |
dc.contributor.affiliationother | Department of Biostatistics, The University of Texas M. D. Anderson Cancer Center, Houston, Texas | en_US |
dc.contributor.affiliationother | Department of Biostatistics, The University of Texas M. D. Anderson Cancer Center, Houston, Texas | en_US |
dc.identifier.pmid | 14534889 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/34380/1/11667_ftp.pdf | en_US |
dc.identifier.doi | http://dx.doi.org/10.1002/cncr.11667 | en_US |
dc.identifier.source | Cancer | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.